Op2Lysis
Pre-clinicalOp2lysis is a biotechnology company that develops innovative medicines for the treatment of hemorrhagic stroke, with its proprietary technology NANOp2Lysis®.
Founded
2017
Focus
Biologics
About
Op2lysis is a biotechnology company that develops innovative medicines for the treatment of hemorrhagic stroke, with its proprietary technology NANOp2Lysis®.
Company Info
TypePrivate
Founded2017
LocationParis, France
StagePre-clinical
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile